Studies presented represent key focus areas, including building evidence for clinical utility of comprehensive genomic profiling; overcoming market access barriers, and progressing the whole-genome approach for MRDSAN DIEGO, May 29, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced some of its latest research being presented at the American Society of Clinical Oncology (ASCO) Annual Meeting, May 31–June 4 in Chicago. Highlights ...

SAN DIEGO, May 28, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today published its fifth annual Corporate Social Responsibility (CSR) Report. The report highlights the company's ongoing commitments and progress made in 2023 toward advancing human health by serving as a champion for patients, communities, employees, and the planet.Illumina released its 2023 CSR Report today, highlighting the company’s ongoing commitments and progress made ...

Ms. Richo brings more than 30 years of regulated-industry experience as an attorney and legal executive, with extensive experience in compliance and business ethics, intellectual property, and corporate litigation. She formerly served as Corporate Senior Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary at Cargill, where she oversaw the company's corporate governance, global ethics and compliance, global security, global government relations, law, and shareholder relations f ...

SAN DIEGO, May 15, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:Bernstein's 40th Annual Strategic Decisions Conference on May 29, 2024Fireside chat at 6:00am Pacific Time (9:00am Eastern Time)The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following ...

Illumina, Inc. (NASDAQ:ILMN) RBC Capital Markets Global Healthcare Call May 14, 2024 8:30 AM ET Company Participants Ankur Dhingra - Chief Financial Officer Salli Schwartz - Investor Relations Conference Call Participants Conor McNamara - RBC Capital Markets Conor McNamara Good morning, everyone. Welcome to RBC Capital Markets 2024 Global Healthcare Conference. I am Conor McNamara, the life science tools and diagnostics analyst at RBC. It’s my pleasure to welcome Illumina to our conference. With me on stage ...

GRAIL to host Capital Markets Day on May 13, 2024  SAN DIEGO, May 6, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that it has publicly filed a Form 10 registration statement with the U.S. Securities and Exchange Commission ("SEC"), in connection with its intended divestiture of GRAIL. A version of this registration statement was submitted to the SEC last December as required. The Form 10 includes detailed information about GRAIL, including historic financial information, a description ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☑ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Quarterly Period Ended March 31, 2024 ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number 001-35406 Illumina, Inc. (Exact name of registrant as specified in its charter) Delaware 33-0804655 (State or other jurisdiction of incorporation ...

SAN DIEGO, May 3, 2024 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference: RBC 2024 Global Healthcare Conference on May 14, 2024Fireside chat at 5:30am Pacific Time (8:30am Eastern Time) The webcast can be accessed through the Investor Info section of Illumina's website at investor.illumina.com. A replay will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumi ...

Illumina, Inc. (NASDAQ:ILMN) Q1 2024 Earnings Call Transcript May 2, 2024 5:00 PM ET Company Participants Salli Schwartz - Vice President, Investor Relations Jacob Thaysen - Chief Executive Officer Ankur Dhingra - Chief Financial Officer Joydeep Goswami - Advisor Conference Call Participants Doug Schenkel - Wolfe Research Puneet Souda - Leerink Partners Vijay Kumar - Evercore ISI Dan Brennan - TD Cowen David Westenberg - Piper Sandler Subha Nambi - Guggenheim Securities Sung Ji Nam - Scotiabank Tejas Savant ...

Investors: Salli Schwartz +1.858.291.6421 ir@illumina.com Media: Bonny Fowler +1.740.641.5579 pr@illumina.com Illumina Reports Financial Results for First Quarter of Fiscal Year 2024 • Core Illumina revenue of $1.06 billion for Q1 2024, down 2% from Q1 2023 (down 2% on a constant currency basis) • Core Illumina GAAP operating margin of 11.0% and non-GAAP operating margin of 20.6% for Q1 2024 • Reiterating fiscal year 2024 Core Illumina revenue guidance that is approximately flat compared to 2023 and a Core ...